Related Experiment Video
Updated: Apr 16, 2026
07:46
Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
26.1K
[Skin diseases and obesity].
Carolina Guerra-Segovia1, Jorge Ocampo-Candiani
1Servicio de Dermatología, Hospital Universitario Dr. José Eleuterio González, Monterrey, Nuevo León, México. jocampo2000@yahoo.com.mx.
Revista Medica Del Instituto Mexicano Del Seguro Social
|March 12, 2015
Summary
Obesity significantly impacts skin health, leading to various dermatological conditions. This review explores common skin diseases associated with obesity and their management.
Area of Science:
- Dermatology
- Endocrinology
- Public Health
Background:
- Obesity is a global health issue linked to lifestyle factors and excess adipose tissue.
- Metabolic changes in obesity profoundly affect skin physiology, predisposing individuals to skin diseases.
- Existing research on obesity's dermatological impact is limited.
Purpose of the Study:
- To review common skin diseases prevalent in individuals with obesity.
- To elucidate the relationship between obesity, metabolic changes, and skin pathologies.
- To provide insights into the clinical features and management of obesity-related skin conditions.
Main Methods:
- Literature review of studies on obesity and skin diseases.
- Analysis of clinical features and etiological factors.
- Synthesis of current knowledge on management strategies.
Main Results:
- Obesity is associated with specific skin conditions influenced by physiological changes and insulin resistance.
- Certain skin pathologies are exacerbated by obesity, including various forms of dermatitis.
- Metabolic alterations in obesity contribute to the development and severity of skin diseases.
Conclusions:
- Obesity-induced metabolic and physiological changes significantly impact skin health.
- Understanding these connections is crucial for effective diagnosis and management of dermatological issues in obese patients.
- Further research is warranted to fully elucidate the complex interplay between obesity and skin diseases.
Related Concept Videos
01:23Skin Diseases and Disorders
6.3K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
6.3K
01:24Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
419
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
419
01:21Drug Dosing: Obese Patients
349
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
349
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
307
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
307
01:02Hypodermis
8.7K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
8.7K